The Boston Globe, By Scott B. Van Voorhis
The job market along the Route 128 corridor is back. And it’s not just all about the corporate giants. A bevy of small and midsize life science and high-tech companies are out front in this welcome trend, helping lead the way. We are talking a few dozen hires here, another dozen or so there. It’s not the kind of stuff that grabs big headlines, but it all adds up.
Take Organogenesis Inc., for example, a Canton biotech company that has said it will add 35 employees.
It’s part of a steady expansion that saw the company, which has developed treatments using living tissue to help heal chronic wounds, severe burns, broken bones, and other maladies, move into a new, $65 million headquarters and research complex last spring. The four-building campus in the Dan Road business park off Route 138 includes the “largest living cell manufacturing facility,” according to the company. Read more.